Taken together, these results suggested that CAPE acts as the inhibitor of TGFβ receptor kinase to block the activation of TGFβ on cell proliferation and invasion in bladder carcinoma cells. This evidence concerns the gene TGFB1 and urinary bladder carcinoma.